Product Information
LISDEXAMFETAMINE 40 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $2.8168 per EA under NDC 00378685777. Its NADAC has been published 142 times since Oct 11, 2023.
Strength
40 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378685777
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA202835On Market Since
8/25/2023
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 40 MG CAPSULE has been published 142 times since Oct 11, 2023, and over the history we have for it it has declined 15.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8168 per EA |
|---|---|
| All-time high | $6.5053 (Mar 13, 2024) |
| All-time low | $2.8168 (Jun 17, 2026) |
| 52-week high | $4.0582 |
| 52-week low | $2.8168 |
| Median price | $4.0582 |
| Average price | $4.1059 |
| Largest weekly change | +41.6% (Jan 17, 2024) |
| Weeks tracked | 142 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lisdexamfetamine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 40 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $2.8168 per EA (NDC 00378685777), effective Jun 24, 2026.
How has the price of LISDEXAMFETAMINE 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 40 MG CAPSULE has declined 15.4%. It has been tracked across 142 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 40 MG CAPSULE?
Since Oct 11, 2023, the NADAC for LISDEXAMFETAMINE 40 MG CAPSULE has ranged from a low of $2.8168 (Jun 17, 2026) to a high of $6.5053 (Mar 13, 2024), with a median of $4.0582 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 40 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LISDEXAMFETAMINE 40 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures LISDEXAMFETAMINE 40 MG CAPSULE?
LISDEXAMFETAMINE 40 MG CAPSULE (NDC 00378685777) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification